Current Understanding of RAD52 Functions: Fundamental and Therapeutic Insights

Total Page:16

File Type:pdf, Size:1020Kb

Current Understanding of RAD52 Functions: Fundamental and Therapeutic Insights cancers Editorial Current Understanding of RAD52 Functions: Fundamental and Therapeutic Insights Vanesa Gottifredi 1,* and Lisa Wiesmüller 2,* 1 Fundación Instituto Leloir, IIBBA-Consejo Nacional de Investigaciones Científicas y Técnicas. Av. Patricias Argentinas 435, 1405 Buenos Aires, Argentina 2 Division of Gynecological Oncology, Department of Obstetrics and Gynecology of the University of Ulm Prittwitzstrasse 43, 89075 Ulm, Germany * Correspondence: [email protected] (V.G.); [email protected] (L.W.); Tel.: +54-11-52387500 (V.G.); +49-731-500 58800 (L.W.) Received: 12 March 2020; Accepted: 13 March 2020; Published: 17 March 2020 Abstract: In this Special Issue, we would like to focus on the various functions of the RAD52 helicase-like protein and the current implications of such findings for cancer treatment. Over the last few years, various laboratories have discovered particular activities of mammalian RAD52—both in S and M phase—that are distinct from the auxiliary role of yeast RAD52 in homologous recombination. At DNA double-strand breaks, RAD52 was demonstrated to spur alternative pathways to compensate for the loss of homologous recombination functions. At collapsed replication forks, RAD52 activates break-induced replication. In the M phase, RAD52 promotes the finalization of DNA replication. Its compensatory role in the resolution of DNA double-strand breaks has put RAD52 in the focus of synthetic lethal strategies, which is particularly relevant for cancer treatment. Keywords: DNA double-strand break repair; common fragile site; stalled replication fork; telomeres; fork reversal; R loops; nucleases; genome integrity 1. Introduction This Special Issue gathers experts in the field to convey both comprehensive, insightful, and current perspectives on the different functions of human RAD52 in the maintenance of genomic integrity and the current implications of such findings for cancer treatment. Historically, RAD52 was described as an auxiliary factor of RAD51 in homologous recombination (HR) in yeast [1]. Around 2000, it became clear that in mammalian cells, BRCA2 had taken over the RAD51-chaperoning activity, stimulating filament formation on single-stranded DNA (ssDNA), while RAD52 was left with the single-strand annealing (SSA) activity [2]. Later, limited contributions of RAD52 to the repair of DNA double-strand breaks (DSBs)—such as during alternative non-homologous end-joining (A-NHEJ) and in compensating for the loss of HR functions—were also detected [3]. Full-length RAD52 forms a heptameric ring, whereby N- and C-terminal parts of each monomer form a positively charged ssDNA binding groove around the heptamer [4,5]. Oligomerization in the cytoplasm stimulates nuclear import, granted by the combined action of individually weak nuclear localization signals. Its RPA binding domains underlie RAD52´s biochemical functions in binding RPA-coated ssDNA, annealing, and homology-directed repair. Even though many details regarding the contribution of posttranslational modification to the function of RAD52 remain to be explored, we know that RAD52 acetylation is required for its accumulation at DSBs, sumoylation of yeast RAD52 for the choice of SSA over canonical recombination at repeats, and tyrosine phosphorylation of RAD52 for ssDNA, rather than dsDNA binding and the choice of SSA [6–9]. Cancers 2020, 12, 705; doi:10.3390/cancers12030705 www.mdpi.com/journal/cancers Cancers 2020, 12, x FOR PEER REVIEW 2 of 8 Cancers 12 Over2020 ,the, 705last years, new functions of RAD52 have been identified. For example, various2 of 8 laboratories have discovered the involvement of mammalian RAD52 and RNA templates and RNA- DNAOver hybrid the structures last years, like new R functions loops in ofunprecedented RAD52 have been homology-directed identified. For example, DSB repair various events laboratories [9]. First, RNAhave discoveredwas discovered the involvement to serve as ofa mammalianbridging template RAD52 in and RAD52- RNA templates and RPA-mediated and RNA-DNA homology- hybrid directedstructures DSB like Rrepair, loops inwhich unprecedented may play homology-directeda role during transcription, DSB repair eventsreplication, [9]. First, class-switch RNA was recombination,discovered to serveand at as telomeres. a bridging Second, template in in tran RAD52-scription-coupled and RPA-mediated HR (TC-HR) homology-directed in G0/G1 cells, DSB R loopsrepair, generated which may during play transcription a role during were transcription, found to be replication, bound by CSB, class-switch followed recombination, by RAD52-mediated, and at BRCA-independenttelomeres. Second, inRAD51 transcription-coupled recruitment, and HRHR. (TC-HR) Third, in in transcription-activated G0/G1 cells, R loops generated HR (TA-HR) during in S/G2transcription cells, RAD52 were recruits found tothe be XPG bound cleaving by CSB, R loops, followed which by gene RAD52-mediated,rates ssDNA overhangs BRCA-independent for BRCA- dependentRAD51 recruitment, HR [9]. and HR. Third, in transcription-activated HR (TA-HR) in S/G2 cells, RAD52 recruitsSurprisingly, the XPG cleaving RAD52 Ralso loops, acts whichduring generates events ot ssDNAher than overhangs canonical forDSB BRCA-dependent repair—namely, HR during [9]. DNASurprisingly, replication when RAD52 it counteracts also acts during excessive events fork other regression, than canonical which DSB may repair—namely, exhaust protection during factors, DNA causingreplication breakage when itof counteracts reversed forks. excessive At collapsed fork regression, replication which forks, may exhaust RAD52 protection activates break-induced factors, causing replicationbreakage of (BIR), reversed a specialized forks. At collapsedpathway replicationthat repairs forks, single-ended RAD52 activates DSBs. During break-induced M phase, replication RAD52- mediated(BIR), a specialized BIR also promotes pathway thatthe finalization repairs single-ended of DNA replication DSBs. During (MiDAS- M phase, mitotic RAD52-mediated DNA synthesis). BIR Notably,also promotes RAD52 the cooperates finalization with of DNAvarious replication nucleases, (MiDAS- namely, mitotic MUS81 DNA during synthesis). BIR, ERCC1/XPF Notably, during RAD52 SSA,cooperates and XPG with during various TA-HR. nucleases, It also namely,cooperates MUS81 with MRE11 during and BIR, MUS81/EME1 ERCC1/XPF during at de-protected SSA, and forks XPG thatduring have TA-HR. reverted It alsoto process cooperates these with structures MRE11 into and HR MUS81 substrates,/EME1 atultimately de-protected enabling forks the that cell have to continuereverted DNA to process replication these structures [10–12]. The into multiple HR substrates, activities ultimately of RAD52 enabling known theto date cell toare continue summarized DNA inreplication Figure 1. [10–12]. The multiple activities of RAD52 known to date are summarized in Figure1. FigureFigure 1. 1. MultipleMultiple roles roles of of RAD52 RAD52 during during DNA DNA replication replication and and repair. repair. ( (AA)) RAD52 RAD52 participates participates in in variousvarious DNA DNA double-strand double-strand break break (DSB) (DSB) repair repair proce processessses by by means means of of its its strand-annealing strand-annealing activities. activities. InIn some some pathways, pathways, RAD52 RAD52 acts acts as as a a backup backup factor factor (e.g., (e.g., HR), HR), while while in in others, others, it it is is absolutely absolutely required, required, e.g.e.g. single-strand single-strand annealing annealing (SSA) (SSA) at at DSBs DSBs and and brea break-inducedk-induced replication replication (BIR) (BIR) at at single-ended single-ended DSBs DSBs (which(which are are not not shown in thisthis scheme)scheme) [[8,9,13],8,9,13], ((BB)) RAD52 RAD52 participates participates in in the the alternative alternative lengthening lengthening of oftelomeres. telomeres. RAD52 RAD52 plays plays a rolea role in in BIR-mediated BIR-mediated elongation elongation of telomeresof telomeres during during pro-metaphase, pro-metaphase, but but also alsopromotes promotes spontaneous spontaneous telomere telomere elongation elongation in in G2, G2, independently independently ofof thethe SLX4 nuclease nuclease [11,14,15]. [11,14,15]. ((CC)) RAD52 RAD52 has has also also been been implicated implicated in in the the facilita facilitationtion of of DSB DSB formation formation by by MUS81 MUS81 in in Chk1-depleted Chk1-depleted cellscells and and during during MiDAS MiDAS [10,16,17]. [10,16,17]. (D (D) DSB-independent) DSB-independent roles roles of ofRAD RAD5252 were were also also reported reported in inS phase.S phase. RAD52 RAD52 prevents prevents unleashed unleashed fork reversal, fork reversal, but once but forks once have forks reversed, have reversed, it can facilitate it can facilitateMRE11- dependentMRE11-dependent degradation degradation of newly ofsynthesized newly synthesized DNA [12,18,19]. DNA [12 Template,18,19]. Template DNA: black, DNA: copied black, strand: copied redstrand: and violet red and strands: violet strands:telomeric telomeric regions. regions. Cancers 2020, 12, 705 3 of 8 Therefore, compensatory roles in the resolution of DSBs, as well as at replication forks, put RAD52 in the focus of synthetic lethal strategies, which is particularly relevant for cancer treatment. Consequently, efforts were made to identify RAD52-inhibitory compounds to kill HR-defective tumor cells in a synthetic lethal fashion [8]. The specific mode of action of these compounds is determined by the above-mentioned biochemical
Recommended publications
  • Understanding the Role of Rad52 in Homologous Recombination for Therapeutic Advancement
    Author Manuscript Published OnlineFirst on October 15, 2012; DOI: 10.1158/1078-0432.CCR-11-3150 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. The Role of Rad52 in Homologous Recombination MOLECULAR PATHWAYS: Understanding the role of Rad52 in homologous recombination for therapeutic advancement Benjamin H. Lok 1,2 and Simon N. Powell 1 1 Memorial Sloan-Kettering Cancer Center, New York, NY 2 New York University School of Medicine, New York, NY Corresponding author: Simon N. Powell, MD PhD Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY Mailing address: 1250 1st Avenue, Box 33, New York, NY 10065 Telephone: 212-639-6072 Facsimile: 212-794-3188 E-mail: [email protected] Conflicts of interest. The authors have no potential conflict of interest to report. 1 Downloaded from clincancerres.aacrjournals.org on September 26, 2021. © 2012 American Association for Cancer Research. Author Manuscript Published OnlineFirst on October 15, 2012; DOI: 10.1158/1078-0432.CCR-11-3150 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. The Role of Rad52 in Homologous Recombination Table of Contents Abstract ......................................................................................................................................................... 2 Background ..................................................................................................................................................
    [Show full text]
  • Mutations in the RAD54 Recombination Gene in Primary Cancers
    Oncogene (1999) 18, 3427 ± 3430 ã 1999 Stockton Press All rights reserved 0950 ± 9232/99 $12.00 http://www.stockton-press.co.uk/onc SHORT REPORT Mutations in the RAD54 recombination gene in primary cancers Masahiro Matsuda1,4, Kiyoshi Miyagawa*,1,2, Mamoru Takahashi2,4, Toshikatsu Fukuda1,4, Tsuyoshi Kataoka4, Toshimasa Asahara4, Hiroki Inui5, Masahiro Watatani5, Masayuki Yasutomi5, Nanao Kamada3, Kiyohiko Dohi4 and Kenji Kamiya2 1Department of Molecular Pathology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Hiroshima 734, Japan; 2Department of Developmental Biology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Hiroshima 734, Japan; 3Department of Cancer Cytogenetics, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Hiroshima 734, Japan; 42nd Department of Surgery, Hiroshima University School of Medicine, 1-2-3 Kasumi, Minami-ku, Hiroshima 734, Japan; 51st Department of Surgery, Kinki University School of Medicine, 377-2 Ohno-higashi, Osaka-sayama, Osaka 589, Japan Association of a recombinational repair protein RAD51 therefore, probable that members of the RAD52 with tumor suppressors BRCA1 and BRCA2 suggests epistasis group are altered in cancer. that defects in homologous recombination are responsible To investigate whether RAD54, a member of the for tumor formation. Also recent ®ndings that a protein RAD52 epistasis group, is mutated in human cancer, associated with the MRE11/RAD50 repair complex is we performed SSCP analysis and direct sequencing of mutated in Nijmegen breakage syndrome characterized PCR products using mRNAs from 132 unselected by increased cancer incidence and ionizing radiation primary tumors including 95 breast cancers, 13 sensitivity strongly support this idea.
    [Show full text]
  • Chang-2017-03-23-DNA-Repair-1.Pdf
    DNA Repair 54 (2017) 1–7 Contents lists available at ScienceDirect DNA Repair journal homepage: www.elsevier.com/locate/dnarepair Short communication Increased genome instability is not accompanied by sensitivity to DNA damaging agents in aged yeast cells MARK Daniele Novarina, Sara N. Mavrova1, Georges E. Janssens2, Irina L. Rempel, ⁎ Liesbeth M. Veenhoff, Michael Chang European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, 9713 AV Groningen, The Netherlands ARTICLE INFO ABSTRACT Keywords: The budding yeast Saccharomyces cerevisiae divides asymmetrically, producing a new daughter cell from the Rad52 original mother cell. While daughter cells are born with a full lifespan, a mother cell ages with each cell division Genome stability and can only generate on average 25 daughter cells before dying. Aged yeast cells exhibit genomic instability, Yeast aging which is also a hallmark of human aging. However, it is unclear how this genomic instability contributes to DNA damage sensitivity aging. To shed light on this issue, we investigated endogenous DNA damage in S. cerevisiae during replicative aging and tested for age-dependent sensitivity to exogenous DNA damaging agents. Using live-cell imaging in a microfluidic device, we show that aging yeast cells display an increase in spontaneous Rad52 foci, a marker of endogenous DNA damage. Strikingly, this elevated DNA damage is not accompanied by increased sensitivity of aged yeast cells to genotoxic agents nor by global changes in the proteome or transcriptome that would indicate a specific “DNA damage signature”. These results indicate that DNA repair proficiency is not compromised in aged yeast cells, suggesting that yeast replicative aging and age-associated genomic instability is likely not a consequence of an inability to repair DNA damage.
    [Show full text]
  • Supplemental Table 1: Snps Genotyped for NCO, Listed Alphabetically by Gene Name
    Supplemental Table 1: SNPs genotyped for NCO, listed alphabetically by gene name. Gene Name SNP rs# ACVR1 rs10497189 ACVR1 rs10497191 ACVR1 rs10497192 ACVR1 rs10933441 ACVR1 rs1146035 ACVR1 rs1220110 ACVR1 rs17182166 ACVR1 rs17798043 ACVR1 rs4380178 ACVR1 rs6719924 ACVR2 rs1128919 ACVR2 rs10497025 ACVR2 rs1424941 ACVR2 rs1424954 ACVR2 rs17742573 ACVR2 rs2382112 ACVR2 rs4419186 AKT2 rs11671439 AKT2 rs12460555 AKT2 rs16974157 AKT2 rs2304188 AKT2 rs3730050 AKT2 rs7250897 AKT2 rs7254617 AKT2 rs874269 ALOX12B/ALOXE3 rs3809881 ALOX15B rs4792147 ALOX15B rs9898751 AMH rs10407022 AMH rs2074860 AMH rs3746158 AMH rs4806834 AMH rs757595 AMH rs886363 AMHR2 rs10876451 AMHR2 rs11170547 AMHR2 rs11170558 APC rs2229992 APC rs351771 APC rs41115 APC rs42427 APC rs459552 APC rs465899 APEX1 rs2275007 APEX1 rs3136820 15 APEX1 rs938883 APEX1 rs11160711 APEX1 rs1713459 APEX1 rs1713460 APEX1 rs1760941 APEX1 rs2275008 APEX1 rs3120073 APEX1 rs4465523 AR rs12011793 AR rs1204038 AR rs1337080 AR rs1337082 AR rs2207040 AR rs2361634 AR rs5031002 AR rs6152 AR rs962458 ATM rs1800058 ATM rs1800889 ATM rs11212570 ATM rs17503908 ATM rs227060 ATM rs228606 ATM rs3092991 ATM rs4987876 ATM rs4987886 ATM rs4987923 ATM rs4988023 ATM rs611646 ATM rs639923 ATM rs672655 ATR rs2229032 ATR rs10804682 ATR rs11920625 ATR rs13065800 ATR rs13085998 ATR rs13091637 ATR rs1802904 ATR rs6805118 ATR rs9856772 BACH1 rs388707 BACH1 rs1153276 BACH1 rs1153280 BACH1 rs1153284 BACH1 rs1153285 BACH1 rs17743655 BACH1 rs17744121 BACH1 rs2300301 BACH1 rs2832283 16 BACH1 rs411697 BACH1 rs425989 BARD1 rs1048108
    [Show full text]
  • DNA Repair by Rad52 Liquid Droplets
    ARTICLE https://doi.org/10.1038/s41467-020-14546-z OPEN DNA repair by Rad52 liquid droplets Roxanne Oshidari 1, Richard Huang1, Maryam Medghalchi1,2, Elizabeth Y.W. Tse3, Nasser Ashgriz2, Hyun O. Lee3,4, Haley Wyatt3,4 & Karim Mekhail 1,4* Cellular processes are influenced by liquid phase separation, but its role in DNA repair is unclear. Here, we show that in Saccharomyces cerevisiae, liquid droplets made up of DNA repair proteins cooperate with different types of DNA damage-inducible intranuclear microtubule filaments (DIMs) to promote the clustering of DNA damage sites and maintain 1234567890():,; genome stability. Rad52 DNA repair proteins at different DNA damage sites assemble in liquid droplets that fuse into a repair centre droplet via the action of petite DIMs (pti-DIMs). This larger droplet concentrates tubulin and projects short aster-like DIMs (aster-DIMs), which tether the repair centre to longer DIMs mediating the mobilization of damaged DNA to the nuclear periphery for repair. Our findings indicate that cooperation between Rad52 liquid droplets and various types of nuclear filaments promotes the assembly and function of the DNA repair centre. 1 Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, MaRS Centre, 661 University Ave., Toronto, ON M5G 1M1, Canada. 2 Multiphase Flow and Phase Systems Laboratory, Department of Mechanical and Industrial Engineering, Faculty of Applied Science and Engineering, University of Toronto, 5 King’s College Circle, M5S 3G8 Toronto, ON, Canada. 3 Department of Biochemistry, Faculty of Medicine, University of Toronto, MaRS Centre, 661 University Ave., Toronto, ON M5G 1M1, Canada. 4 Canada Research Chairs Program, Faculty of Medicine, University of Toronto, 1 King’s College Circle, M5S 1A8 Toronto, ON, Canada.
    [Show full text]
  • Gene Expression Profiling in Werner Syndrome Closely Resembles That of Normal Aging
    Gene expression profiling in Werner syndrome closely resembles that of normal aging Kasper J. Kyng*†, Alfred May*, Steen Kølvraa‡, and Vilhelm A. Bohr*§ *Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224; and ‡Department of Human Genetics, University of Aarhus, DK-8000 Aarhus C, Denmark Edited by Philip C. Hanawalt, Stanford University, Stanford, CA, and approved August 19, 2003 (received for review February 6, 2003) Werner syndrome (WS) is a premature aging disorder, displaying We used cDNA microarrays to study expression of 6,912 RNA defects in DNA replication, recombination, repair, and transcrip- pol II transcribed genes in a panel of 15 primary human tion. It has been hypothesized that several WS phenotypes are fibroblast cell lines derived from normal young donors, normal secondary consequences of aberrant gene expression and that a old donors, and WS patients. transcription defect may be crucial to the development of the syndrome. We used cDNA microarrays to characterize the expres- Materials and Methods sion of 6,912 genes and ESTs across a panel of 15 primary human Cell Lines and Culture Conditions. Fifteen primary human skin fibroblast cell lines derived from young donors, old donors, and WS fibroblast cell lines were obtained from Coriell Cell Repositories patients. Of the analyzed genes, 6.3% displayed significant differ- (Camden, NJ) and classified into three groups based on geno- ences in expression when either WS or old donor cells were type as listed in Table 1: normal young (avg. 22.5 yr, n ϭ 6), compared with young donor cells. This result demonstrates that normal old (avg.
    [Show full text]
  • DNA Annealing by Rad52 Protein Is Stimulated by Specific Interaction with the Complex of Replication Protein a and Single-Stranded DNA
    Proc. Natl. Acad. Sci. USA Vol. 95, pp. 6049–6054, May 1998 Biochemistry DNA annealing by Rad52 Protein is stimulated by specific interaction with the complex of replication protein A and single-stranded DNA TOMOHIKO SUGIYAMA,JAMES H. NEW, AND STEPHEN C. KOWALCZYKOWSKI* Sections of Microbiology and of Molecular and Cellular Biology, University of California, Davis, CA 95616-8665 Communicated by I. Robert Lehman, Stanford University School of Medicine, Stanford, CA, March 30, 1998 (received for review January 2, 1998) ABSTRACT Homologous recombination in Saccharomy- otides (14, 15). More recent reports show that Rad52 protein ces cerevisiae depends critically on RAD52 function. In vitro, stimulates DNA strand exchange mediated by Rad51 protein, Rad52 protein preferentially binds single-stranded DNA which is a homologue of the E. coli RecA protein (16–19). In (ssDNA), mediates annealing of complementary ssDNA, and the yeast system, stimulation is due to Rad52 protein interac- stimulates Rad51 protein-mediated DNA strand exchange. tion with, and alleviation of an inhibitory consequence of Replication protein A (RPA) is a ssDNA-binding protein that ssDNA binding by, replication protein A (RPA), which is the is also crucial to the recombination process. Herein we report homologue of ssDNA binding protein (SSB) protein (16–18). that Rad52 protein effects the annealing of RPA–ssDNA RPA is a heterotrimeric complex consisting of polypeptides complexes, complexes that are otherwise unable to anneal. with molecular masses of 70.4, 29.9, and 13.8 kDa (20, 21). The The ability of Rad52 protein to promote annealing depends on primary structure of RPA is well-conserved in yeast, human, both the type of ssDNA substrate and ssDNA binding protein.
    [Show full text]
  • Interactive Competition Between Homologous Recombination and Non-Homologous End Joining
    Vol. 1, 913–920, October 2003 Molecular Cancer Research 913 Interactive Competition Between Homologous Recombination and Non-Homologous End Joining Chris Allen,1 James Halbrook,2 and Jac A. Nickoloff1 1Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, and 2ICOS Corporation, Bothell, WA Abstract distinct, non-conservative HR process that can result in DNA-dependent protein kinase (DNA-PK), composed of deletions when interacting regions are arranged as direct Ku70, Ku80, and the catalytic subunit (DNA-PKcs), is repeats (1). Key HR proteins include RAD51, five RAD51 involved in double-strand break (DSB) repair by non- paralogues, RAD52, and RAD54 (2–8). Several other proteins homologous end joining (NHEJ). DNA-PKcs defects have poorly defined roles in HR, including replication protein confer ionizing radiation sensitivity and increase A (RPA), p53, ATM, BRCA1, and BRCA2 (9–14). In yeast, homologous recombination (HR). Increased HR is con- Rad50 and Mre11 have been implicated in HR, particularly in sistent with passive shunting of DSBs from NHEJ to HR. an early step involving end processing to 3V single-stranded tails We therefore predicted that inhibiting the DNA-PKcs (15). HR typically results in accurate repair, while defects in kinase would increase HR. A novel DNA-PKcs inhibitor HR proteins cause genome instability (6, 16–18). (1-(2-hydroxy-4-morpholin-4-yl-phenyl)-ethanone; desig- NHEJ often results in imprecise repair, yielding deletions or nated IC86621) increased ionizing radiation sensitivity insertions, yet NHEJ also plays a role in maintaining genome but surprisingly decreased spontaneous and DSB- stability (19, 20).
    [Show full text]
  • Mutational Signatures Reveal the Role of RAD52 in P53-Independent P21 Driven Genomic Instability
    bioRxiv preprint doi: https://doi.org/10.1101/195263; this version posted September 28, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Mutational signatures reveal the role of RAD52 in p53-independent p21 driven genomic instability Panagiotis Galanos1,2*, George Pappas1,2*, Alexander Polyzos3, Athanassios Kotsinas1, Ioanna Svolaki1, Nikos N Giakoumakis4, Christina Glytsou5, Ioannis S Pateras1, Umakanta Swain6, Vassilis Souliotis7, Alexander Georgakilas8, Nicholas Geacintov9, Luca Scorrano5, Claudia Lukas10, Jiri Lukas10, Zvi Livneh6, Zoi Lygerou4, Claus Storgaard Sørensen11, Jiri Bartek2,12,13**, Vassilis G. Gorgoulis1,3,14** 1. Molecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, National Kapodistrian University of Athens, 75 Mikras Asias Str, Athens, GR-11527, Greece. 2. Danish Cancer Society Research Centre, Strandboulevarden 49, Copenhagen, DK-2100, Denmark. 3. Biomedical Research Foundation of the Academy of Athens, 4 Soranou Ephessiou Str, Athens, GR-11527, Greece. 4. Laboratory of Biology, School of Medicine, University of Patras, 26505, Rio, Patras, Greece 5. Department of Biology, University of Padova, Padova 35121, Italy 6. Dept. of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 76100, Israel 7. Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 48 Vassileos Constantinou Ave, Athens, GR-11635, Greece 8. Physics Department, School of Applied Mathematical and Physical Sciences, National Technical University of Athens (NTUA), Zografou 15780, Athens, Greece bioRxiv preprint doi: https://doi.org/10.1101/195263; this version posted September 28, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder.
    [Show full text]
  • RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based Chemotherapy
    International Journal of Molecular Sciences Article RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based Chemotherapy Jonas Herrmann 1,* , Helena Schmidt 1, Katja Nitschke 1, Cleo-Aron Weis 2, Philipp Nuhn 1, Jost von Hardenberg 1, Maurice Stephan Michel 1, Philipp Erben 1 and Thomas Stefan Worst 1 1 Department of Urology, University Medical Centre Mannheim, 68167 Mannheim, Germany; [email protected] (H.S.); [email protected] (K.N.); [email protected] (P.N.); [email protected] (J.v.H.); [email protected] (M.S.M.); [email protected] (P.E.); [email protected] (T.S.W.) 2 Institute for Pathology, University Medical Centre Mannheim, 68167 Mannheim, Germany; [email protected] * Correspondence: [email protected]; Tel.: +49-621-383-2201 Abstract: Background: Perioperative cisplatin-based chemotherapy (CBC) can improve the outcome of patients with muscle-invasive bladder cancer (MIBC), but it is still to be defined which patients benefit. Mutations in DNA damage response genes (DDRG) can predict the response to CBC. The value of DDRG expression as a marker of CBC treatment effect remains unclear. Material and Citation: Herrmann, J.; Schmidt, H.; methods: RNA expression of the nine key DDRG (BCL2, BRCA1, BRCA2, ERCC2, ERCC6, FOXM1, Nitschke, K.; Weis, C.-A.; Nuhn, P.; RAD50, RAD51, and RAD52) was assessed by qRT-PCR in a cohort of 61 MICB patients (median age von Hardenberg, J.; Michel, M.S.; 66 y, 48 males, 13 females) who underwent radical cystectomy in a tertiary care center.
    [Show full text]
  • Inhibition of RAD52-Based DNA Repair for Cancer Therapy
    University of Nebraska Medical Center DigitalCommons@UNMC Theses & Dissertations Graduate Studies Spring 5-5-2018 Inhibition of RAD52-based DNA repair for cancer therapy Mona Al-Mugotir University of Nebraska Medical Center Follow this and additional works at: https://digitalcommons.unmc.edu/etd Part of the Biochemistry Commons, and the Molecular Biology Commons Recommended Citation Al-Mugotir, Mona, "Inhibition of RAD52-based DNA repair for cancer therapy" (2018). Theses & Dissertations. 286. https://digitalcommons.unmc.edu/etd/286 This Dissertation is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It has been accepted for inclusion in Theses & Dissertations by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. Inhibition of RAD52-based DNA repair for cancer therapy By Mona Hadi Al-Mugotir A DISSERTATION Presented to the Faculty of the University of Nebraska Graduate College in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Biochemistry & Molecular Biology Graduate Program Under the Supervision of Professor Gloria E. O. Borgstahl University of Nebraska Medical Center Omaha, Nebraska April, 2018 Supervisory Committee: Amarnath Natarajan, Ph.D. Justin L. Mott, M.D.- Ph.D. Youri I. Pavlov, Ph.D. Acknowledgment Any line I could think of to start my acknowledgment contains the phrase “my mother.” My mother has a generous, giving nature that drove her since early times in her life to assume motherhood responsibilities towards her younger siblings which continued in full capacity as she became a parent herself for the eight surviving of us. Not a single time in my life growing up do I recall her going to a bakery to buy bread.
    [Show full text]
  • Functional Validation of Rare Human Genetic Variants Involved in Homologous Recombination Using Saccharomyces Cerevisiae
    RESEARCH ARTICLE Functional Validation of Rare Human Genetic Variants Involved in Homologous Recombination Using Saccharomyces cerevisiae Min-Soo Lee1,MiYu1, Kyoung-Yeon Kim2, Geun-Hee Park1, KyuBum Kwack2*, Keun P. Kim1* 1 Department of Life Science, Chung-Ang University, Seoul, Korea, 2 Department of Biomedical Science, CHA University, Seongnam, Korea * [email protected] (KPK); [email protected] (KBK) Abstract Systems for the repair of DNA double-strand breaks (DSBs) are necessary to maintain ge- OPEN ACCESS nome integrity and normal functionality of cells in all organisms. Homologous recombination Citation: Lee M-S, Yu M, Kim K-Y, Park G-H, Kwack (HR) plays an important role in repairing accidental and programmed DSBs in mitotic and K, Kim KP (2015) Functional Validation of Rare meiotic cells, respectively. Failure to repair these DSBs causes genome instability and can Human Genetic Variants Involved in Homologous induce tumorigenesis. Rad51 and Rad52 are two key proteins in homologous pairing and Recombination Using Saccharomyces cerevisiae. strand exchange during DSB-induced HR; both are highly conserved in eukaryotes. In this PLoS ONE 10(5): e0124152. doi:10.1371/journal. pone.0124152 study, we analyzed pathogenic single nucleotide polymorphisms (SNPs) in human RAD51 and RAD52 using the Polymorphism Phenotyping (PolyPhen) and Sorting Intolerant from Academic Editor: Alvaro Galli, CNR, ITALY Tolerant (SIFT) algorithms and observed the effect of mutations in highly conserved do- Received: July 25, 2014 mains of RAD51 and RAD52 on DNA damage repair in a Saccharomyces cerevisiae-based Accepted: March 10, 2015 system. We identified a number of rad51 and rad52 alleles that exhibited severe DNA repair Published: May 4, 2015 defects.
    [Show full text]